Creative Medical Technology Holdings, Inc. (CELZ)
$0.82-2.38%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 1.90
- P/E (TTM)
- -0.41
- Short % float
- 6.91%
- Days to cover
- 1.0
- SI change
- +95.6%
- 1W
- -8.89%
- 1M
- -6.82%
- vs SPY 1W
- -8.75%
- vs SPY 1M
- -9.32%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 10
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-52.0%
REV YoY-
ROE-86.7%
EPS YoY-
ROA-64.4%
GROSS-1732
OP-208004
NET-201355
[VALUATION]
P/E TTM-0.41
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B0.35
P/FCF-
EV/EBITDA1.08
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO12.91
ND/EBITDA-
BETA1.90
Company news
FAQ
- What is LOPJLB’s current signal on CELZ?
- LOPJLB’s latest quantitative signal on Creative Medical Technology Holdings, Inc. (CELZ) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CELZ in?
- Creative Medical Technology Holdings, Inc. (CELZ) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Creative Medical Technology Holdings, Inc. (CELZ) do?
- Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivit…